All News

The federal government levies hefty fines for breaches but doesn't have to follow its own rules.

New report from America's Health Insurance Plans outlines how negative social determinants of health are being addressed by federal and state agencies.

Researchers can determine the best treatments for skin disorders, like atopic dermatitis and ringworm, by first observing how they benefit pets with the same conditions.

Study assessed the patterns of care for biologic-dosing outliers and nonoutliers in patients with rheumatoid arthritis.

A cardiovascular outcomes trial has already shown a reduction in cardiovascular events, but not deaths.

A new oral dosage form of olaparib (Lynparza) has been approved as maintenance treatment in women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, who are in a complete or partial response to platinum-based chemotherapy.

Patient preferences for multiple sclerosis therapies are important to take into account and are increasingly so as alternatives to traditional injection therapies are developed to address adherence issues.

A new study in the American Journal of Public Health finds that rates of suicide by firearm were more common than non-firearm suicides in the most rural areas.

Study finds there is little evidence to suggest that an oxycodone HCI extended-release tablets nonformulary restriction has a direct effect on patient enrollment behavior.

A small phase 1b trial of pembrolizumab in patients with small-cell lung cancer shows that the immunotherapy drug had a favorable safety profile and demonstrated “promising” antitumor activity.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

This week, the top managed care articles included a report from the Congressional Budget Office on the impact of eliminating the cost-sharing reduction payments; a decision from CMS to eliminate 2 mandatory bundled payment programs; and a new value-based alliance that called for ending use of a test for diagnosing heart attacks.

A free-market system with competition should lead to reduced prices and savings-theoretically. In the case of healthcare, being able to shop around for the best priced service or product not only isn’t easy, but isn't always feasible.

Researchers from the Harvard School of Public Health studied an average of 27 national polls on the Affordable Care Act taken by 12 different organizations.

Researchers from the United States, Netherlands, and Denmark have collaborated on developing a new liquid biopsy test that can detect circulating cell-free DNA in patients with early-stage cancer.

A letter from CMS lays out 2 options for New Hampshire: either stop accepting donations from hospitals to fund Medicaid expansion or have the program’s federal funding revoked.

The findings suggest identifying children at risk of T2D and fixing their sleep could be a low-cost way to head off type 2 diabetes.

The Institute for Clinical and Economic Review (ICER) released a Final Evidence Report that found an absence of sufficient evidence to confirm the efficacy of abuse-deterrent formulations (ADFs) of opioids in decreasing the opioid abuse levels of the greater population.

A new study, published in the journal Nature, has confirmed the efficacy of a melanoma vaccine targeted against 20 predicted personal tumor neoantigens in 6 patients.

We all shop. Every day we decide which products and services to buy. But shopping for medical care, typically, has been different.

Gastroenterologists favorably view Janus kinase (JAK) inhibitors for utilization in treating inflammatory bowel disease (IBD), according to a recent survey conducted by Decision Resources Group.

Cardiologists were thrilled with results of the FOURIER trial, but payers were less moved. Given the drug's $14,000 a year price, some wanted to know if they would see more than the 30% to 35% discounts they had been offered.

Following completion of their chemotherapy regimen, many women who have survived cancer experience lingering symptoms of chemotherapy-induced peripheral neuropathy, according to a new study.

As HHS celebrates National Health Center Week by announcing $105 million in grants for quality improvement, a study indicates that practice transformation may be taking a toll on satisfaction among clinicians and staff at some federally qualified health centers.

An analysis by Kaiser Health News found that Medicaid incurred billions of dollars in extra spending as a result of price increases for hundreds of common drugs from 2015 to 2016, including decades-old branded drugs and generics used to treat cancer.

A retrospective study in patients with newly diagnosed cancer has identified an increased risk of cardiovascular (CV) abnormalities that are aggravated by cancer stage.

Since taking office, President Donald Trump has toyed with the idea of eliminating the cost-sharing reduction (CSR) payments to insurers under the Affordable Care Act (ACA). Doing so would actually decrease the number of uninsured individuals starting in 2020, but would increase the federal deficit by $194 billion from 2017 through 2026, according to a new report released by the Congressional Budget Office (CBO).